GP

Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round

Retrieved on: 
Friday, January 5, 2024

By providing a way to standardize measurements for efficiency and accuracy, CRISPR QC enables pharmaceutical and agriculture companies to quickly screen for the best therapeutics to develop into next generation personalized medicines.

Key Points: 
  • By providing a way to standardize measurements for efficiency and accuracy, CRISPR QC enables pharmaceutical and agriculture companies to quickly screen for the best therapeutics to develop into next generation personalized medicines.
  • Chris Yoo, Ph.D., GP of Xcellerant Ventures, says “With CRISPR-based gene editing, we are at the beginning of a truly precise way to treat and cure thousands of genetically-driven diseases.
  • Xcellerant Ventures is a leader in investing in startups that can combine technological advances across industries into solutions that make healthcare more precise, more affordable, and more accessible.
  • It was instantly clear to us that Xcellerant Ventures was the investor and partner we have been searching for, and we are excited and honored to have Xcellerant lead our Series A."

Passthrough Report Reveals 66.4% Of Fund Managers In The US Are Increasing Fund Targets In 2024 Despite Pessimistic Market Predictions

Retrieved on: 
Friday, January 5, 2024

Passthrough, a leader in investor onboarding automation for fund managers and other fintechs, today released its 2024 Fundraising Predictions Report.

Key Points: 
  • Passthrough, a leader in investor onboarding automation for fund managers and other fintechs, today released its 2024 Fundraising Predictions Report.
  • Specifically, the report looked into the state of capital raising tied to market conditions based on 2024 insights and predictions from fund managers.
  • “Fund managers are coming back to market because you can only sit on the sidelines for so long.
  • In fact, 41.35% of fund managers believe that market competitiveness will be the primary driver for ESG integration.

United Kingdom Private GP EHR Market Forecasts to 2028: Rising Demand for Private GP Services in the UK Increases Need for EHR Management Solutions

Retrieved on: 
Friday, January 5, 2024

DUBLIN , Jan. 4, 2024 /PRNewswire/ --  The "United Kingdom Private GP EHR Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN , Jan. 4, 2024 /PRNewswire/ --  The "United Kingdom Private GP EHR Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The various benefits associated with private GP services such as flexibility, efficiency, speed, and prolonged consultation time are driving the demand for private GPs in the UK.
  • Therefore, the rise in private GP service demand offers an opportunity for the expansion of the private GP EHR market for effective maintenance and management of rising patient data in the sector.
  • For instance, a leading company in the UK EHR market, TPP is using NLP technology to integrate AI into its EHR product, SystmOne EHR used by many GP practices in the UK.

GP Strategies Joins Forces with Quantum5 to Transform Automotive Retail Industry Support

Retrieved on: 
Wednesday, January 3, 2024

COLUMBIA, Md., Jan. 3, 2024 /PRNewswire/ -- GP Strategies (GP) and Quantum5 (Q5) are joining forces to bring workforce insights and leading-edge learning solutions to OEMs and automotive retail networks in service of the modern learner and a frictionless retail experience.

Key Points: 
  • COLUMBIA, Md., Jan. 3, 2024 /PRNewswire/ -- GP Strategies (GP) and Quantum5 (Q5) are joining forces to bring workforce insights and leading-edge learning solutions to OEMs and automotive retail networks in service of the modern learner and a frictionless retail experience.
  • Automotive retail is changing rapidly, and so are learning and the learner.
  • "We think of ourselves as the Tesla of the learning industry," said Ken Herfurth, Co-Founder and Chief Vision Officer for Q5.
  • We are excited to partner with GP Strategies and to have the opportunity to level up the learning experience across automotive and other industries."

Mizuho Expands its Global Private Capital Advisory Platform

Retrieved on: 
Wednesday, December 13, 2023

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Mizuho Americas today announced it is integrating the primary capital advisory services of Capstone Partners and the secondary liquidity solutions business of Greenhill Private Capital Advisory under a newly created Mizuho Private Capital Advisory platform, serving general partners (GPs) and limited partners (LPs) with a comprehensive set of solutions.

Key Points: 
  • NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Mizuho Americas today announced it is integrating the primary capital advisory services of Capstone Partners and the secondary liquidity solutions business of Greenhill Private Capital Advisory under a newly created Mizuho Private Capital Advisory platform, serving general partners (GPs) and limited partners (LPs) with a comprehensive set of solutions.
  • Greenhill Private Capital Advisory, part of Greenhill and Co. acquired earlier this month, and Capstone Partners, acquired last year, will retain their distinct brands, leadership, and market leading capabilities.
  • Mizuho Private Capital Advisory will be run by Clay Deniger and Greenhill Private Capital Advisory by co-heads, Bernhard Engelien and Lloyd Bradbury.
  • “With Capstone Partners and Greenhill Private Capital Advisory joining forces, Mizuho is uniquely positioned to provide alternatives and their investors with trusted advice and integrated solutions throughout the private investment lifecycle.”
    Mizuho Private Capital Advisory will bring together 55+ professionals across offices in New York, London, Dallas, Frankfurt, Geneva and Hong Kong.

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Associa

Retrieved on: 
Tuesday, November 28, 2023

REDWOOD CITY, Calif. And SHANGHAI, China, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) and Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180) announced today the publication of the final overall survival (OS) results from the pivotal JUPITER-02 study (NCT03581786), a randomized, double-blind, placebo-controlled, international, multi-center Phase 3 clinical trial evaluating the immune checkpoint inhibitor LOQTORZI™ (toripalimab-tpzi), in combination with the chemotherapy agents gemcitabine and cisplatin, as a first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) in the Journal of the American Medical Association (JAMA). As previously reported at the 2023 American Society of Clinical Oncologists (ASCO) Annual Meeting, the final analysis revealed a 37% reduction in the risk of death in NPC patients treated with toripalimab plus chemotherapy versus chemotherapy alone.

Key Points: 
  • Coherus plans to launch LOQTORZI in the United States in January 2024.
  • “There are limited options for patients living with this aggressive head and neck cancer.
  • The median OS was not reached in the LOQTORZI arm and was 33.7 months in the placebo arm.
  • The safety profile was consistent with that previously reported in other toripalimab clinical trials and consistent with the PD-1 inhibitor class.

GDS Holdings Limited Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 22, 2023

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced its unaudited financial results for the third quarter ended September 30, 2023.

Key Points: 
  • SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced its unaudited financial results for the third quarter ended September 30, 2023.
  • Gross profit margin was 17.8% in the third quarter of 2023, compared with 20.8% in the third quarter of 2022, and 22.3% in the second quarter of 2023 or 20.0% after excluding the abovementioned one-time service revenue in the second quarter.
  • Research and development costs were RMB10.5 million (US$1.4 million) in the third quarter of 2023, compared with RMB6.7 million in the third quarter 2022 and RMB5.0 million in the second quarter of 2023.
  • Others, net for the third quarter of 2023 was RMB21.7 million (US$3.0 million), compared with RMB27.4 million in the third quarter of 2022 and RMB20.2 million in the second quarter of 2023.

Gamer Pakistan Announces Share Repurchase Program

Retrieved on: 
Tuesday, November 21, 2023

HENDERSON, Nev. and NOWSHERA, Pakistan, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Gamer Pakistan Inc. (NASDAQ: GPAK) (“GP”), an early-stage technology and esports company focused on game development and in-game AI community engagement, and organizing esports events in Pakistan, today announced that its Board of Directors has approved a share repurchase program, with authorization to purchase from time to time at the direction of the Board, up to $1.0 million of its common stock.

Key Points: 
  • HENDERSON, Nev. and NOWSHERA, Pakistan, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Gamer Pakistan Inc. (NASDAQ: GPAK) (“GP”), an early-stage technology and esports company focused on game development and in-game AI community engagement, and organizing esports events in Pakistan, today announced that its Board of Directors has approved a share repurchase program, with authorization to purchase from time to time at the direction of the Board, up to $1.0 million of its common stock.
  • “We are committed to driving long-term value for our stockholders and in strategically deploying GP’s resources and capital,” said Gamer Pakistan CEO James Knopf.
  • “We are confident in our market opportunity and given the strength of our balance sheet the share repurchase program is an investment in our long-term growth.
  • The share buyback program may be suspended or discontinued at any time and does not obligate the company to acquire any amount of common stock.

In Major Expansion of Private Funds Group, Houlihan Lokey Creates Best-in-Class Private Capital Advisory Platform With Acquisition of Triago

Retrieved on: 
Thursday, December 21, 2023

Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced a major expansion of its Private Funds Group to establish the Group as one of the preeminent global private capital advisory platforms.

Key Points: 
  • Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced a major expansion of its Private Funds Group to establish the Group as one of the preeminent global private capital advisory platforms.
  • The Triago team will join Houlihan Lokey’s Private Funds Group (PFG), led by Global Co-Heads Andy Lund and Cristina Forcina Westermann.
  • Triago CEO Matt Swain will join as Head of Direct Placements and Secondaries, a new practice within PFG.
  • Triago’s founder and chairman, Antoine Dréan, will join as Chairman Emeritus of the Private Funds Group.

Asante Capital Group Celebrates 2023 Achievements, Extends Track Record of Successful Fundraises and Grows Global Team

Retrieved on: 
Monday, December 18, 2023

Asante Capital Group (“Asante”), a leading independent private equity placement and advisory group, is pleased to announce an exceptional year, continuing its record of successful fundraising, strengthening its global presence and capabilities, and facilitating discussions from industry experts and the Asante team on key topics driving private equity.

Key Points: 
  • Asante Capital Group (“Asante”), a leading independent private equity placement and advisory group, is pleased to announce an exceptional year, continuing its record of successful fundraising, strengthening its global presence and capabilities, and facilitating discussions from industry experts and the Asante team on key topics driving private equity.
  • “Despite continued uncertainty in the market, 2023 was a year of strong performance for Asante and its partners.
  • Notably, Asante has also completed successful fundraisings accounting for two-thirds of all funds closed in China through 2023.
  • Asante also saw another year of strong internal growth with several senior promotions and the continued expansion of its global team.